학술논문
Efficacy and safety in a 4-year follow-up of the ELEVATE-TN study comparing acalabrutinib with or without obinutuzumab versus obinutuzumab plus chlorambucil in treatment-naïve chronic lymphocytic leukemia
Document Type
Article
Author
Sharman, J.P.; Egyed, M.; Jurczak, W.; Skarbnik, A.; Pagel, J.M.; Flinn, I.W.; Kamdar, M.; Munir, T.; Walewska, R.; Corbett, G.; Fogliatto, L.M.; Herishanu, Y.; Banerji, V.; Coutre, S.; Follows, G.; Walker, P.; Karlsson, K.; Ghia, P.; Janssens, A.; Cymbalista, F.; Woyach, J.A.; Byrd, J.C.; Ferrant, E.; Wierda, W.G.; Munugalavadla, V.; Yu, T.; Wang, M.H.
Source
In: Leukemia . (Leukemia, April 2022, 36(4):1171-1175)
Subject
Language
English
ISSN
14765551
08876924
08876924